Maternal hypertension and feto-placental growth restriction is reversed by sildenafil: Evidence of independent effects of circulating nitric oxide levels
- PMID: 29355552
- DOI: 10.1016/j.ejphar.2018.01.010
Maternal hypertension and feto-placental growth restriction is reversed by sildenafil: Evidence of independent effects of circulating nitric oxide levels
Abstract
Sildenafil has shown nitric oxide (NO)-independent pleiotropic effects, however the mechanisms involved are unclear. We investigated the protective effects of sildenafil against hypertension in pregnancy and feto-placental growth restriction induced by NO inhibition, and if sodium nitrite-derived NO formation influences sildenafil effects. We evaluated the plasmatic levels of NO metabolites, cyclic guanosine monophosphate (cGMP), oxidative stress and myeloperoxidase, which are involved in endothelial dysfunction during hypertension in pregnancy. Also, we performed in vitro experiments to examine cell viability and NO synthesis in human umbilical vein endothelial cells (HUVECs) cultures incubated with plasma from healthy or hypertensive pregnant rats treated (or not) with both drugs, either alone or in association. Sildenafil blunted hypertension in pregnancy and protected against feto-placental growth restriction induced by NO inhibition and these effects of sildenafil alone were similar to those presented by its association with sodium nitrite. Protective effects of sildenafil were observed even with low plasmatic NO levels and were not followed by increases in cGMP levels. Also, sildenafil, but not sodium nitrite, blunted the increases in myeloperoxidase activity. Both drugs (isolated or in association) presented antioxidant effects. Plasma from hypertensive pregnant rats treated with sildenafil, but not sodium nitrite alone, increased the viability of HUVECs. NO synthesis in HUVECs cultures was increased with plasma from rats treated with both drugs. We conclude that sildenafil effects are not dependent of circulating NO levels in hypertension and feto-placental growth restriction. These findings may reflect a protection against myeloperoxidase and pro-oxidant activation in hypertension in pregnancy.
Keywords: Hypertension; N(G)-nitro-L-arginine methyl ester; Pregnancy; Rats; Sildenafil citrate; Sodium nitrite.
Copyright © 2018 Elsevier B.V. All rights reserved.
Similar articles
-
Sildenafil treatment in a nonsevere hypertensive murine model lowers blood pressure without reducing fetal growth.Am J Obstet Gynecol. 2016 Sep;215(3):386.e1-8. doi: 10.1016/j.ajog.2016.05.002. Epub 2016 May 10. Am J Obstet Gynecol. 2016. PMID: 27177526
-
Sodium nitrite attenuates hypertension-in-pregnancy and blunts increases in soluble fms-like tyrosine kinase-1 and in vascular endothelial growth factor.Nitric Oxide. 2016 Jul 1;57:71-78. doi: 10.1016/j.niox.2016.05.004. Epub 2016 May 12. Nitric Oxide. 2016. PMID: 27181106
-
Placental nitric oxide formation and endothelium-dependent vasodilation underlie pravastatin effects against angiogenic imbalance, hypertension in pregnancy and intrauterine growth restriction.Basic Clin Pharmacol Toxicol. 2019 Apr;124(4):385-393. doi: 10.1111/bcpt.13149. Epub 2018 Nov 15. Basic Clin Pharmacol Toxicol. 2019. PMID: 30318719
-
The effects of sildenafil in maternal and fetal outcomes in pregnancy: A systematic review and meta-analysis.PLoS One. 2019 Jul 24;14(7):e0219732. doi: 10.1371/journal.pone.0219732. eCollection 2019. PLoS One. 2019. Retraction in: PLoS One. 2024 Sep 6;19(9):e0310291. doi: 10.1371/journal.pone.0310291. PMID: 31339910 Free PMC article. Retracted.
-
Nitric oxide and the biology of pregnancy.Vascul Pharmacol. 2018 Nov;110:71-74. doi: 10.1016/j.vph.2018.07.004. Epub 2018 Aug 1. Vascul Pharmacol. 2018. PMID: 30076925 Review.
Cited by
-
Decrease in Nitric Oxide Production as a Key Mediator in the Pathogenesis of Preeclampsia and a Potential Therapeutic Target: A Case-Control Study.Biomedicines. 2022 Oct 20;10(10):2653. doi: 10.3390/biomedicines10102653. Biomedicines. 2022. PMID: 36289915 Free PMC article.
-
Short-term outcomes of phosphodiesterase type 5 inhibitors for fetal growth restriction: a study protocol for a systematic review with individual participant data meta-analysis, aggregate meta-analysis, and trial sequential analysis.Syst Rev. 2021 Dec 3;10(1):305. doi: 10.1186/s13643-021-01849-5. Syst Rev. 2021. PMID: 34861900 Free PMC article.
-
Serum from patients with hypertension promotes endothelial dysfunction to induce trophoblast invasion through the miR‑27b‑3p/ATPase plasma membrane Ca2+ transporting 1 axis.Mol Med Rep. 2021 May;23(5):319. doi: 10.3892/mmr.2021.11958. Epub 2021 Mar 24. Mol Med Rep. 2021. PMID: 33760199 Free PMC article.
-
Reductions of Circulating Nitric Oxide are Followed by Hypertension during Pregnancy and Increased Activity of Matrix Metalloproteinases-2 and -9 in Rats.Cells. 2019 Nov 7;8(11):1402. doi: 10.3390/cells8111402. Cells. 2019. PMID: 31703340 Free PMC article.
-
Evidence of Nitric Oxide Impairment During Hypertensive Pregnancies.Adv Exp Med Biol. 2023;1428:99-125. doi: 10.1007/978-3-031-32554-0_5. Adv Exp Med Biol. 2023. PMID: 37466771 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials